Abstract
Amikacin, combined with aztreonam, piperacillin, or ticarcillin, synergistically inhibited amikacin-resistant sputum isolates of Pseudomonas aeruginosa and P. cepacia from children with cystic fibrosis. Ticarcillin-amikacin was the least active combination. Aminoglycoside resistance should not preclude the use of beta-lactam-aminoglycoside combinations in the treatment of pulmonary infections in cystic fibrosis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berenbaum M. C. Correlations between methods for measurement of synergy. J Infect Dis. 1980 Sep;142(3):476–480. doi: 10.1093/infdis/142.3.476. [DOI] [PubMed] [Google Scholar]
- Hyatt A. C., Chipps B. E., Kumor K. M., Mellits E. D., Lietman P. S., Rosenstein B. J. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis. J Pediatr. 1981 Aug;99(2):307–314. doi: 10.1016/s0022-3476(81)80486-6. [DOI] [PubMed] [Google Scholar]
- Norrby R., Friberg K., Holm S. E. In-vitro antibacterial activity of SQ 26,776. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):69–76. doi: 10.1093/jac/8.suppl_e.69. [DOI] [PubMed] [Google Scholar]
- Percival A., Thomas E., Hart C. A., Karayiannis P. In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):49–55. doi: 10.1093/jac/8.suppl_e.49. [DOI] [PubMed] [Google Scholar]
- Reeves D. S., Bywater M. J., Holt H. A. Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):57–68. doi: 10.1093/jac/8.suppl_e.57. [DOI] [PubMed] [Google Scholar]
- Scribner R. K., Marks M. I., Weber A. H., Tarpay M. M., Welch D. F. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother. 1982 Jun;21(6):939–943. doi: 10.1128/aac.21.6.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strandberg D. A., Jorgensen J. H., Drutz D. J. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agents Chemother. 1983 Aug;24(2):282–286. doi: 10.1128/aac.24.2.282. [DOI] [PMC free article] [PubMed] [Google Scholar]